BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 36225939)

  • 1. Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma.
    Yang J; Zhang J; Na S; Wang Z; Li H; Su Y; Ji L; Tang X; Yang J; Xu L
    Front Immunol; 2022; 13():994034. PubMed ID: 36225939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
    Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
    Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing to Identify an Immunogenic Cell Death-Related 5-Gene Prognostic Signature in Hepatocellular Carcinoma.
    Peng L; Xu S; Xu JL
    J Hepatocell Carcinoma; 2024; 11():879-900. PubMed ID: 38770169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
    Han S; Wang Q; Shen M; Zhang X; Wang J
    Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of single-cell and bulk RNA sequencing data reveals prognostic characteristics of lysosome-dependent cell death-related genes in osteosarcoma.
    Wu Y; Yang J; Xu G; Chen X; Qu X
    BMC Genomics; 2024 Apr; 25(1):379. PubMed ID: 38632516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of immunogenic cell death-applied prediction model for esophageal carcinoma.
    Wen Y; You D; Bai Y; Cao J; Zhang L; Xia X
    Am J Cancer Res; 2023; 13(5):2104-2115. PubMed ID: 37293167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas.
    Kuang Y; Jiang B; Zhu H; Zhou Y; Huang H; Li C; Zhang W; Li X; Cao Y
    Front Immunol; 2023; 14():1102094. PubMed ID: 37153540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment.
    Ren J; Yang J; Na S; Wang Y; Zhang L; Wang J; Liu J
    Front Immunol; 2022; 13():998653. PubMed ID: 36211436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
    Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
    Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
    Hong X; Fu R
    PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma.
    Zong Y; Cao Y; Zhang D; Guan X; Zhang F; Shen Z; Yin F
    Sci Rep; 2023 Jun; 13(1):9118. PubMed ID: 37277499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering programmed cell death mechanisms in osteosarcoma for prognostic modeling.
    Chen J; Fan T; Pan L; Yang H
    Environ Toxicol; 2024 Apr; ():. PubMed ID: 38622876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics.
    Shu Y; Peng J; Feng Z; Hu K; Li T; Zhu P; Cheng T; Hao L
    Front Oncol; 2022; 12():941724. PubMed ID: 36212395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Cell RNA Sequencing Pro-angiogenic Macrophage Profiles Reveal Novel Prognostic Biomarkers and Therapeutic Targets for Osteosarcoma.
    Yi C; Li Z; Zhao Q; Gong D; Zhao S; Chen Z; Cheng C; Bian E; Tian D
    Biochem Genet; 2024 Apr; 62(2):1325-1346. PubMed ID: 37603193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and comprehensive analysis of a novel prognostic signature associated with immunogenic cell death molecular subtypes in patients with bladder cancer.
    Gu L; Hu G; Hu J; Wen F
    Heliyon; 2023 Aug; 9(8):e18848. PubMed ID: 37593621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.
    Wu J; Jin Z; Lin J; Fu Y; Wang J; Shen Y
    Front Immunol; 2022; 13():992266. PubMed ID: 36405691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
    Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
    Front Immunol; 2022; 13():919231. PubMed ID: 35967366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential prognostic prediction model for metastatic osteosarcoma based on bioinformatics analysis.
    Wang Y; Ming G; Gao B
    Acta Orthop Belg; 2023 Sep; 89(3):373-380. PubMed ID: 37935218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Analysis of Multi-Omics Data to Establish a Hypoxia-Related Prognostic Model in Osteosarcoma.
    Tong Y; Zhang X; Zhou Y
    Evol Bioinform Online; 2022; 18():11769343221128537. PubMed ID: 36325183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma.
    Huang W; Xiao Y; Wang H; Chen G; Li K
    Front Endocrinol (Lausanne); 2022; 13():1047433. PubMed ID: 36387908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.